The Limited Times

Now you can see non-English news...

Covid-19: Pfizer targeting Omicron subvariants soon to be approved in Europe

2022-08-10T11:38:27.867Z


The European Medicines Agency (EMA) could approve an anti-Covid vaccine from Pfizer / BioNTech targeting two sub-variants in the fall.


The European Medicines Agency (EMA) could approve a Pfizer/BioNTech Covid vaccine targeting two fast-spreading subvariants of the Omicron strain as early as the fall, a spokesperson for the regulator said on Wednesday.

The EMA expects to receive an application for the adapted BA.4/5 vaccine developed by Pfizer /BioNTech, which will be evaluated for potential rapid approval in the fall

,” a spokesperson told AFP. .

Source: lefigaro

All news articles on 2022-08-10

You may like

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z
News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.